Gut Microbiota and Diabetes

Résumé fourni par la source

Commentaryfibers.SCFAs serve multiple roles, including maintaining gut barrier integrity, regulating immune function, and providing energy to colonocytes.In a healthy gut, a balance between the predominant bacterial phyla, especially Firmicutes and Bacteroidetes, is essential for optimal metabolic and immune regulation.Firmicutes are key producers of butyrate, an SCFA critical for maintaining gut barrier function and possessing anti-inflammatory properties.Bacteroidetes, on the other hand, are involved in breaking down complex carbohydrates and polysaccharides, contributing to energy balance and immune modulation.The gut microbiota also plays an essential role in interacting with the immune system, primarily through the gut-associated lymphoid tissue (GALT).The GALT forms part of the mucosal immune system and helps maintain a delicate balance IntroductIonThe gut microbiota, an intricate ecosystem comprising trillions of microorganisms, has emerged as a significant player in various metabolic and immune functions in the human body.Recent advancements in microbiome research have highlighted the essential role that the gut microbiota plays in maintaining overall health and its implications in metabolic disorders such as obesity, diabetes mellitus, and cardiovascular diseases.Both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) have been linked to imbalances in the gut microbiota, also known as dysbiosis, which can influence the onset, progression, and therapeutic outcomes of these diseases.1 Diabetes mellitus, a chronic condition characterized by hyperglycemia, is caused either by the body's inability to produce insulin (T1DM) or by insulin resistance combined with an inadequate compensatory insulin secretion (T2DM).The growing prevalence of diabetes has placed a significant burden on healthcare systems worldwide.2 Exploring the gut microbiota's role in diabetes provides new insights into possible preventive and therapeutic strategies.This review aims to elaborate on the relationship between gut microbiota and diabetes, focusing on how dysbiosis contributes to disease development and progression, and how manipulating the microbiota through diet, probiotics, or medications can offer novel therapeutic avenues. Gut MIcrobIota I n HealtH a n d dIsease Composition and Function of Gut MicrobiotaThe human gastrointestinal (GI) tract harbors a diverse community of microorganisms, including bacteria, archaea, fungi, viruses, and protozoa.Bacteria form the bulk of this community and can be grouped into several phyla, of which Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria dominate.These microorganisms play a pivotal role in various physiological processes, including digestion, vitamin synthesis, and immune response modulation.Importantly, gut bacteria produce short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, through the fermentation of dietary